196 related articles for article (PubMed ID: 35628777)
1. Heme Oxygenase-1 (
Imre A; Kovács R; Tóth Z; Majoros L; Benkő Z; Pfliegler WP; Pócsi I
J Fungi (Basel); 2022 May; 8(5):. PubMed ID: 35628777
[TBL] [Abstract][Full Text] [Related]
2. Virulence Factors and in-Host Selection on Phenotypes in Infectious Probiotic Yeast Isolates (
Imre A; Kovács R; Pázmándi K; Nemes D; Jakab Á; Fekete T; Rácz HV; Dóczi I; Bácskay I; Gácser A; Kovács K; Majoros L; Farkas Z; Pócsi I; Pfliegler WP
J Fungi (Basel); 2021 Sep; 7(9):. PubMed ID: 34575784
[No Abstract] [Full Text] [Related]
3. A new, rapid multiplex PCR method identifies frequent probiotic origin among clinical Saccharomyces isolates.
Imre A; Rácz HV; Antunovics Z; Rádai Z; Kovács R; Lopandic K; Pócsi I; Pfliegler WP
Microbiol Res; 2019 Oct; 227():126298. PubMed ID: 31421716
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic.
Wombwell E; Bransteitter B; Gillen LR
Mycoses; 2021 Dec; 64(12):1521-1526. PubMed ID: 34585799
[TBL] [Abstract][Full Text] [Related]
5. Review article: yeast as probiotics -- Saccharomyces boulardii.
Czerucka D; Piche T; Rampal P
Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
[TBL] [Abstract][Full Text] [Related]
6. A Mutation in
Liu JJ; Zhang GC; Kong II; Yun EJ; Zheng JQ; Kweon DH; Jin YS
Appl Environ Microbiol; 2018 May; 84(10):. PubMed ID: 29523547
[TBL] [Abstract][Full Text] [Related]
7. Enhancing probiotic impact: engineering
de Carvalho BT; Subotić A; Vandecruys P; Deleu S; Vermeire S; Thevelein JM
Appl Environ Microbiol; 2024 Jun; 90(6):e0032524. PubMed ID: 38752748
[No Abstract] [Full Text] [Related]
8. Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae.
Posteraro B; Sanguinetti M; Romano L; Torelli R; Novarese L; Fadda G
Int J Food Microbiol; 2005 Sep; 103(3):295-304. PubMed ID: 16099314
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Saccharomyces fungemia: A systematic review.
Vinayagamoorthy K; Pentapati KC; Prakash H
Med Mycol; 2023 Feb; 61(2):. PubMed ID: 36806741
[TBL] [Abstract][Full Text] [Related]
10. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast
Offei B; Vandecruys P; De Graeve S; Foulquié-Moreno MR; Thevelein JM
Genome Res; 2019 Sep; 29(9):1478-1494. PubMed ID: 31467028
[TBL] [Abstract][Full Text] [Related]
11. Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use.
Martin IW; Tonner R; Trivedi J; Miller H; Lee R; Liang X; Rotello L; Isenbergh E; Anderson J; Perl T; Zhang SX
Diagn Microbiol Infect Dis; 2017 Mar; 87(3):286-288. PubMed ID: 28024866
[TBL] [Abstract][Full Text] [Related]
12. Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient.
Landaburu MF; López Daneri GA; Relloso S; Zarlenga LJ; Vinante MA; Mujica MT
Rev Argent Microbiol; 2020; 52(1):27-30. PubMed ID: 31262611
[TBL] [Abstract][Full Text] [Related]
13. Yeasts as probiotics: Mechanisms, outcomes, and future potential.
Sen S; Mansell TJ
Fungal Genet Biol; 2020 Apr; 137():103333. PubMed ID: 31923554
[TBL] [Abstract][Full Text] [Related]
14. Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administration.
Poncelet A; Ruelle L; Konopnicki D; Miendje Deyi VY; Dauby N
Infect Dis Now; 2021 May; 51(3):293-295. PubMed ID: 33934809
[TBL] [Abstract][Full Text] [Related]
15. Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.
Hudson LE; Fasken MB; McDermott CD; McBride SM; Kuiper EG; Guiliano DB; Corbett AH; Lamb TJ
PLoS One; 2014; 9(11):e112660. PubMed ID: 25391025
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Engineering of Probiotic Saccharomyces boulardii.
Liu JJ; Kong II; Zhang GC; Jayakody LN; Kim H; Xia PF; Kwak S; Sung BH; Sohn JH; Walukiewicz HE; Rao CV; Jin YS
Appl Environ Microbiol; 2016 Apr; 82(8):2280-2287. PubMed ID: 26850302
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome-wide differences between Saccharomyces cerevisiae and Saccharomyces cerevisiae var. boulardii: Clues on host survival and probiotic activity based on promoter sequence variability.
Pais P; Oliveira J; Almeida V; Yilmaz M; Monteiro PT; Teixeira MC
Genomics; 2021 Mar; 113(2):530-539. PubMed ID: 33482324
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii.
Datta S; Timson DJ; Annapure US
J Sci Food Agric; 2017 Jul; 97(9):3039-3049. PubMed ID: 27868205
[TBL] [Abstract][Full Text] [Related]
19. Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory.
Jin Y; Yu S; Liu JJ; Yun EJ; Lee JW; Jin YS; Kim KH
Microb Cell Fact; 2021 Aug; 20(1):160. PubMed ID: 34407819
[TBL] [Abstract][Full Text] [Related]
20. Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements.
Rannikko J; Holmberg V; Karppelin M; Arvola P; Huttunen R; Mattila E; Kerttula N; Puhto T; Tamm Ü; Koivula I; Vuento R; Syrjänen J; Hohenthal U
Emerg Infect Dis; 2021 Aug; 27(8):2090-6. PubMed ID: 34287140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
